Quick Takeaways
- Mark Schoenberg has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,854,754.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Mark Schoenberg
- Location
- Ra Anana, Israel
- Summary
- The estimated net worth of Mark Schoenberg is at least $2,854,754 dollars as of 04 Feb 2026. Mark Schoenberg is the Chief Medical Officer of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $2.85M.
- Signature
- /s/ Jason D. Smith, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Mark Schoenberg and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: UroGen Pharma Ltd. ($2,854,754).
- Past-year value change for that position: -$725,315.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Mark Schoenberg
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Chief Medical Officer | $2,854,754 | -$725,315 | -20% | 03 Feb 2026 |
Insider Transactions Reported by Mark Schoenberg:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.